TCM
GILD icon

Teza Capital Management’s Gilead Sciences GILD Stock Holding History

Teza Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,587
Closed -$398K – 148
2025
Q2 		$398K Sell
3,587
-5,765
-62% -$614K 0.3% 128
2025
Q1 		$1.05M Buy
+9,352
New +$965K 0.48% 46
2024
Q4 		– Sell
-19,007
Closed -$1.59M – 603
2024
Q3 		$1.59M Sell
19,007
-10,967
-37% -$837K 0.17% 172
2024
Q2 		$2.06M Sell
29,974
-20,663
-41% -$1.38M 0.25% 126
2024
Q1 		$3.71M Buy
50,637
+4,715
+10% +$363K 0.49% 54
2023
Q4 		$3.72M Buy
45,922
+19,264
+72% +$1.5M 0.62% 32
2023
Q3 		$2M Buy
+26,658
New +$2.05M 0.32% 80
2023
Q2 		– Sell
-35,914
Closed -$2.98M – 628
2023
Q1 		$2.98M Buy
+35,914
New +$2.97M 0.64% 25
2022
Q4 		– Sell
-17,718
Closed -$1.09M – 632
2022
Q3 		$1.09M Buy
17,718
+9,496
+115% +$599K 0.23% 122
2022
Q2 		$508K Sell
8,222
-50,534
-86% -$3.13M 0.19% 190
2022
Q1 		$3.49M Buy
58,756
+21,035
+56% +$1.34M 1.31% 6
2021
Q4 		$2.74M Buy
37,721
+27,176
+258% +$1.87M 0.73% 26
2021
Q3 		$737K Buy
+10,545
New +$741K 0.35% 83
2021
Q2 		– Sell
-61,968
Closed -$4M – 605
2021
Q1 		$4M Buy
61,968
+42,674
+221% +$2.75M 0.8% 22
2020
Q4 		$1.12M Buy
19,294
+1,501
+8% +$90.6K 0.64% 39
2020
Q3 		$1.12M Sell
17,793
-17,376
-49% -$1.2M 0.66% 26
2020
Q2 		$2.71M Buy
+35,169
New +$2.7M 0.6% 31
2020
Q1 		– Sell
-11,737
Closed -$763K – 285
2019
Q4 		$763K Sell
11,737
-25,524
-69% -$1.66M 0.21% 152
2019
Q3 		$2.36M Buy
+37,261
New +$2.44M 0.6% 20
2018
Q3 		– Sell
-14,338
Closed -$1.02M – 446
2018
Q2 		$1.02M Buy
14,338
+995
+7% +$70.3K 0.15% 223
2018
Q1 		$1.01M Buy
13,343
+398
+3% +$31.6K 0.24% 169
2017
Q4 		$927K Buy
+12,945
New +$983K 0.56% 27

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Teza Capital Management's GILD Position: Q3 2025 in Review

Teza Capital Management sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 3,587 shares — an estimated $398K sold.

Teza Capital Management first reported a position in GILD in Q4 2017 and held it in 22 quarters. The position peaked at $4M in Q1 2021. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

  • Teza Capital Management reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
  • Teza Capital Management sold 3,587 Gilead Sciences shares in Q3 2025, an estimated $398K.
  • Teza Capital Management first reported a position in Gilead Sciences in Q4 2017 and held it in 22 quarters.
  • Teza Capital Management's Gilead Sciences position peaked at $4M in Q1 2021.
  • 2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on Teza Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.